DCGI Finds First MRNA Vaccine Safe, Gives Nods For Phase 2/3 Trials

[email protected]21 Oct, 2021News

The Drug Controller General of India has approved the Phase 2 and 3 clinical trials of India?s first Covid-19 mRNA vaccine. Pune-based pharma major Gennova Biopharmaceuticals Ltd is developing the nation?s first mRNA-based Covid-19 vaccine. It is among a few pharmaceutical firms worldwide, including Moderna Inc and Pfizer Inc, to use mRNA technology in its coronavirus shot. These vaccines do not use a live virus to generate an immune response but prompt the human body to make a protein that triggers one.